Your browser doesn't support javascript.
loading
Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
Sellas I Fernandez, Agustí; Juanola Roura, Xavier; Alonso Ruiz, Alberto; Rosas, José; Medina Luezas, Julio; Collantes Estevez, Eduardo; Abad Hernández, Miguel Ángel; Carrasco Benitez, Virginia; Fisac, Cesar.
Afiliación
  • Sellas I Fernandez A; Hospital Vall d'Hebron, Barcelona, Spain.
  • Juanola Roura X; Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Alonso Ruiz A; Hospital de Cruces, Baracaldo, Vizcaya, Spain.
  • Rosas J; Hospital Marina Baixa Villajoyosa, Alicante, Spain.
  • Medina Luezas J; Hospital Clínico Universitario de Valladolid, Valladolid, Spain.
  • Collantes Estevez E; Hospital Universitario Reina Sofía/IMIBIC, Universidad de Córdoba, Córdoba, Spain.
  • Abad Hernández MÁ; Hospital Virgen del Puerto, Plasencia, Cáceres, Spain.
  • Carrasco Benitez V; Medical Department, Abbvie Spain, Avenida de Burgos, 91, 28050, Madrid, Spain.
  • Fisac C; Medical Department, Abbvie Spain, Avenida de Burgos, 91, 28050, Madrid, Spain. cesar.fisac@abbvie.com.
Rheumatol Int ; 37(11): 1817-1823, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28918450
The objective of the study was to study the clinical utility of the Ankylosing Spondylitis Disease Activity Score (ASDAS) for the assessment of disease activity in ankylosing spondylitis (AS) patients, compared to the Bath Ankylosing Spondylitis Activity Index (BASDAI). This was a prospective longitudinal observational study in patients with AS (NY-modified criteria) from 23 Spanish centers. Physical and analytical data; global, lumbar, and nocturnal pain; ASDAS, BASDAI and minimally acceptable clinical status (PASS) were collected. Psychometric characteristics of both indexes were analyzed: construct validity (convergent and divergent), discriminant capacity, criterion validity (global physician and patient assessment), and sensitivity to change. The study involved 127 patients (19.7% attrition). Both BASDAI and ASDAS showed a higher correlation with patient's global assessment (r = 0.76 and 0.70, respectively) than with physician's global assessment (r = 0.67 and 0.57). Both scores allowed discriminating patients with an acceptable clinical status, although BASDAI to a greater extent than ASDAS (Cohen δ 1.72 vs 0.88 for the medical PASS). Both scores showed sensitivity to change in patients who changed from an unacceptable symptomatic state to acceptable according to PASS criteria (physician and patient) and by BASDAI 50 response criteria (Cohen δ > 0.80). BASDAI showed better criterion validity than ASDAS, both for the patient PASS (AUC 0.85 vs 0.79) and for the physician's (AUC 0.90 vs 0.79). ASDAS shows adequate performance for disease activity in patients with AS; however, in this study, its psychometric properties do not present advantages over BASDAI in terms of criterion validity, sensitivity to change or discriminative capacity; replacement of BASDAI by ASDAS is not supported by the data.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espondilitis Anquilosante / Índice de Severidad de la Enfermedad Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espondilitis Anquilosante / Índice de Severidad de la Enfermedad Tipo de estudio: Observational_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Rheumatol Int Año: 2017 Tipo del documento: Article País de afiliación: España Pais de publicación: Alemania